AGTC is developing treatments for rare lung and eye diseases, offering hope to patients with unmet medical needs. With a highly specializ...
AGTC is developing treatments for rare lung and eye diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, we use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. We use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide. 

The innovative delivery method AGTC uses is the non-toxic adeno-associated virus (AAV), a safe virus that delivers healthy copies of the gene, replacing defective copies.
  • Gene Therapy Explained - Duration: 4 minutes, 31 seconds.

    • 1 year ago
    Many diseases have a genetic basis, which means that the disease is caused by mutated genes which provide incorrect instructions that cause the cell to produce abnormal protein, or disable producti...
  • Foundation Park: a Home for Life Science Innovation in North Central Florida - Duration: 2 minutes, 26 seconds.

    • 2 years ago
    In February 2016, AGTC announced the opening of a new combined use corporate office and laboratory facility in the rapidly growing North Central Florida biotech corridor. The facility is located wi...
  • Sheep with Achromatopsia Are Able to Navigate a Maze After Gene Therapy - Duration: 2 minutes, 10 seconds.

    • 2 years ago
    Sheep affected by achromatopsia (a genetic cause of blindness) are dramatically better able to navigate a maze after receiving gene therapy.

    For each animal, you see its ear tag before treatment ...
  • About the University of Florida Office of Technology Licensing - Duration: 3 minutes, 34 seconds.

    • 2 years ago
    The University of Florida Office of Technology Licensing’s mission is to help transfer University of Florida discoveries from the laboratory towards the market, in order to make the world a better ...
  • Michigan State University, UPenn and AGTC’s Gene Therapy Proof-of-Concept for Achromatopsia - Duration: 114 seconds.

    • 3 years ago
    CNGB3- Achromatopsia is caused by a gene mutation that results in extremely poor visual acuity, photophobia, day blindness and complete loss of color discrimination.

    It affects dogs as well as hum...
  • AGTC CEO Sue Washer's Presentation at the ARM's 3rd Annual Regen Med Investor Day - Duration: 12 minutes.

    • 3 years ago
    Sue Washer, AGTC President and CEO, provided a company presentation at the Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day in which she discussed key corporate milestones and...
  • AGTC’s Technology - Duration: 2 minutes, 53 seconds.

    • 3 years ago
    How does AGTC's gene therapy work? Find out from our experts.
  • AGTC speaks with OIS Co-Chair Gil Kliman at the OIS@AAO Innovator Award Presentation - Duration: 4 minutes, 40 seconds.

    • 3 years ago
    AGTC CEO Sue Washer, after winning the OIS@AAO Innovator award, sits down with Dr. Bill Hauswirth and OIS Co-Chair Gil Kliman to discuss AGTC’s technology and role in the gene therapy industry.
  • AGTC’s Sue Washer featured on The Corridor Magazine’s Faces of Technology - Duration: 2 minutes, 39 seconds.

    • 3 years ago
    Sue Washer speaks to The Corridor Magazine, a publication of The Florida High Tech Council, about innovation at AGTC
  • AGTC’s Sue Washer on Ophthalmology IPOs - Duration: 3 minutes, 6 seconds.

    • 3 years ago
    AGTC CEO, Sue Washer, speaks with fellow CEOs about ophthalmology IPOs.
  • AGTC Technology’s Effect on Canines - Duration: 45 seconds.

    • 3 years ago
    Watch the effect AGTC's gene therapy technology has on a canine.
  • AGTC: A Great Place To Work - Duration: 3 minutes, 6 seconds.

    • 3 years ago
    What makes AGTC a great place to work? Hear from our team about why they love working at AGTC.
  • AGTC Company Overview - Duration: 2 minutes, 21 seconds.

    • 3 years ago
    Learn about AGTC, what we do, and our focus on rare diseases.
to add this to Watch Later

Add to

Loading playlists...